Solid-State Characterization
Characterization and control of inhalation APIs (Active Pharmaceutical Ingredients) are among the core technologies for developing inhalation powder products, includes crystalline forms, amorphous content, crystal habits, particle size distribution, surface energy, specific surface area, surface texture, and mass-to-charge ratio to achieve optimal particle deposition and absorption in the lungs.
Mixing Energy
Inhalation powder products typically consist of a small amount of active ingredient and a carrier. Research on mixing and enabling in different mixers and the study of different process parameter settings are conducted to achieve the optimal balance and control of powder flowability and dispersibility.
Commercialization Production
The pilot and industrial-scale production of inhalation powders are significantly influenced by equipment, processes, and environmental temperature and humidity. It is necessary to conduct in-depth studies on batch uniformity and scale-up influencing factors to achieve the perfect combination of the drug powder and the device.
DPI Device Development
We employ our core technical capabilities in conceptual design, computer pre-validation, and device functionality and performance evaluation to offer device support services for different formulations. This includes considerations of pharmaceutical properties such as drug loading and delivery, ergonomic features such as appearance and usability, and industrial factors such as large-scale production and assembly.
Discrete Element Method
Using Discrete Element Method (DEM) particle simulation technology, we simulate the trajectory and state of particles within the device to determine the optimal geometric shape of the flow path, improve design efficiency, and ensure drug efficacy.
IVIVC Studies
The correlation between in vitro and in vivo performance of pulmonary drug delivery products is one of the most challenging frontier topics. We collaborates with EMMACE Consulting in Sweden to contribute to advancements in pulmonary drug delivery technology.